Venetoclax Plus Hypomethylating Agents May Offer Treatment Backbone for High-Risk AML
Over half of patients with TP53-mutated acute myeloid leukemia who received the combination therapy experienced a response.
Over half of patients with TP53-mutated acute myeloid leukemia who received the combination therapy experienced a response.
Researchers did not find a significant difference in survival outcomes for high- and low-risk patients with follicular lymphoma receiving immunotherapy.
A report on oncofertility identifies the optimal multidisciplinary team for assuring that young patients with cancer can preserve their fertility and the options available to them for family building.
An analysis of how functional outcomes are measured in patients with soft tissue sarcoma revealed the efficacy of salvage surgery, and a need to improve frequency of FO measurements.
Patients who received androgen therapy demonstrated improvements in erythroid, platelet, and neutrophil measures.
An assessment of a population of patients with CML revealed that some are not receiving guideline-based treatment, including TKIs.
Although statistically insignificant, results of a randomized study determined the potential for nurse-led interventions as adjunct posttreatment care for lymphoma survivors.
Antibiotic treatment with carbapenem for S. aureus infection was efficacious in patients with cutaneous T-cell lymphomas.
Inferior survival for patients with chronic lymphocytic leukemia who progress with lymphadenopathy.
The rate of 5-year overall survival in patients with myelodysplastic syndrome who underwent second allogeneic hematopoietic stem cell transplantation was 25.3%.